A Cost-Effectiveness Analysis of Emicizumab Tre...

By HEOR Staff Writer

April 17, 2024

Introduction: The Future of Haemophilia A Treatment When it comes to rare blood diseases, the introduction of Emicizumab, a bispecific monoclonal antibody, has been a significant milestone in the
Innovative Technology Policy: Simulation Modelling in Healthcare
Evaluating the Impact of Molnupiravir in COVID-19 Treatment
Strategic Cost Implications of Medical Countermeasure Stockpiling
Innovations in Surgery: Clinical and Economic Implications
The Cost-Effectiveness of GaitSmart Rehabilitation Programme
Cost-saving Implications of Correct Antibiotic Use
The Socioeconomic Impact of Cervical Cancer in the UK
Risk Prediction in Healthcare and Cost-Effectiveness Analysis
Advancing Obesity Treatment with Endoscopic Sleeve Gastroplasty
Health Economics and Outcomes Research in Global Healthcare
Health Technology Access Pool (HTAP) by the WHO
Understanding and Alleviating Healthcare System Pressure: A Conceptual Framework